CD11b immunophenotyping has been used to discriminate distinct immune profiles in lung inflammatory processes [24], whereas in COVID-19, we and others have highlighted the direct correlation between the increased CD11b+/CD11b- ratio to more adverse symptoms [13,25]. Here, ITGAM is linked to COVID-19.